Obesity | Fox Lake Towing and Recovery

Tag: obesity

The Top 10 Health Care Stories of 2010

by Melly Alazraki on Dec.29, 2010, under Towing

The health-care reform bill, drug and food recalls, medical breakthroughs, layoffs and lawsuits helped make 2010 an exciting year for health care.

Led by the health insurance reform law, a flurry of drug and food recalls, key medical breakthroughs and plenty of layoffs and lawsuits, 2010 proved to be an exciting — if not always positive — year. Here’s our rundown of the biggest health care stories.

Continue reading The Top 10 Health Care Stories of 2010

The Top 10 Health Care Stories of 2010 originally appeared on DailyFinance on Wed, 29 Dec 2010 07:30:00.

Filed Under: Health Care, Genzyme Corporation , Johnson & Johnson, Pfizer, Sanofi Aventis, Merck, GlaxoSmithKline, Novartis, Abbott, Astrazeneca

Leave a Comment :@aoloriginal, Abbott, ABT, ACL, ACTC, affordable care act, AGN, aids, aids prevention, aids research, aids treatments, ARNA, AstraZeneca, AZN, benadryl recall 2010, biotech, biotech layoffs, cheese recall, childrens medicine, childrens medicine recall, diet drugs, egg recall, egg recall 2010, employer benefits, employer healthcare, fda, FDA Food Safety Modernization Act, fda warning, food safety, food safety bill, GENZ, Genzyme Corporation, GERN, GILD, glaxosmithkline, GSK, health benefits, Health Care, health care reform, health insurance, health insurance costs, Health insurance premiums, health insurance reform, HIV AIDS, hiv prevention, HIV treatment, j j, JNJ, JNJ, GILD, OREX, ARNA, VVUS, AZN, PFE, MRK, NVS, ACL, SNY, GENZ, AGN, ABT, GSK, GERN, ACTC, RHHBY, Johnson & Johnson, johnson and johnson, Medicaid, Merck, motrin recall, MRK, Mylanta, Novartis, NVS, obesity, OREX, pfe, Pfizer, pharma, pharma layoffs, pharmaceutical industry, RHHBY, rolaids recall 2010, sanofi-aventis, SNY, VVUS, weight loss more...

Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year

by Melly Alazraki on Oct.29, 2010, under Towing

Vivus shares are soaring this morning, even though the U.S. Food and Drug Administration rejected the drugmaker’s obesity drug Qnexa yesterday. Investors are hoping that the FDA’s rejection, which includes a request for more safety data — not another clinical trial — will lead to approval next year.

Continue reading Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year

Vivus Shares Rally on Hopes Obesity Drug Will Gain Approval Next Year originally appeared on DailyFinance on Fri, 29 Oct 2010 11:10:00.

Filed Under: Company News, Health Care, Stocks in the News

Leave a Comment :ABT, ARNA, Company News, diet drugs, diet pills, drug approval, fda, Health Care, obesity, obesity in America, obesity medication, obesity pills, obesity treatment, OREX, Orexigen, pharmaceutical companies, pharmaceutical stocks, Stocks in the News, Vivus, VVUS, VVUS, ABT, ARNA, OREX more...

Former McDonald’s Manager Not Lovin’ His Weight Gain

by Danny King on Oct.28, 2010, under Towing

McDonald’s has lost a $17,500 lawsuit from a former franchise manager in Brazil, who says he put on 65 pounds during his 12 years of working for the chain. The former employee blames the company’s policy of mandatory food sampling and free employee lunches for his weight gain.

Continue reading Former McDonald’s Manager Not Lovin’ His Weight Gain

Former McDonald’s Manager Not Lovin’ His Weight Gain originally appeared on DailyFinance on Thu, 28 Oct 2010 19:00:00.

Filed Under: Company News, McDonald’s, Retail

Leave a Comment :Brazil, Company News, employee, employee health, employee safety, employees, fast food, food and beverage, franchise, franchises, labor, MCD, mcdonald, mcdonalds, McDonalds Corp, McDonalds Corporation, mcdonalds lawsuit, obesity, restaurant, restaurants, retail, weight gain more...

Abbott Pulls Weight Loss Drug Meridia from the Market

by Melly Alazraki on Oct.08, 2010, under Towing

Drug and medical-device maker Abbott Laboratories announced Friday that it will voluntarily withdraw its controversial obesity drug Meridia, (sibutramine) from the U.S. market at the request of the FDA, due to concerns it increases the risk of heart attacks and strokes.

Continue reading Abbott Pulls Weight Loss Drug Meridia from the Market

Abbott Pulls Weight Loss Drug Meridia from the Market originally appeared on DailyFinance on Fri, 08 Oct 2010 16:14:00.

Filed Under: Company News, Health Care, Abbott, Stocks in the News

Leave a Comment :Abbott, Abbott Laboratories, Abbott pulls meridia, ABT, best weight loss, Company News, diet drug, diet pills, fda, food and drug administration, Health Care, heart attack, lose weight, Meridia, meridia health risks, obesity, obesity drug, overweight, scout, sibutramine, Stocks in the News, stroke, weight loss, weight loss drugs, weight loss pills more...

Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars

by Melly Alazraki on Oct.07, 2010, under Towing

A new study from Columbia University finds that the reasons America is lagging other countries aren’t the commonly cited obesity, smoking, traffic fatalities and homicide. Rather, the problem has been poor health care, or rather, a poor health care system.

Continue reading Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars

Why Americans Lag in Life Expectancy — Even as Health Care Spending Soars originally appeared on DailyFinance on Thu, 07 Oct 2010 12:50:00.

Filed Under: Economy, Health Care